BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/30/2024 2:58:47 PM | Browse: 45 | Download: 96
 |
Received |
|
2024-06-17 06:59 |
|
Peer-Review Started |
|
2024-06-17 06:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-18 05:22 |
|
Revised |
|
2024-08-20 03:12 |
|
Second Decision |
|
2024-08-26 02:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-08-26 06:46 |
|
Articles in Press |
|
2024-08-26 06:46 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-08-29 02:11 |
|
Publish the Manuscript Online |
|
2024-10-30 14:58 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Immunotherapy for metastatic gastric cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chang-Fei Li, Li-Li Lian, Qiu-Ru Li and Yan Jiao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yan Jiao, Doctor, MD, PhD, Doctor, Doctor, Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun 130021, Jilin Province, China. lagelangri1@126.com |
| Key Words |
Immunotherapy; Metastatic; Gastric cancer; Combined therapy; Programmed cell death 1 ligand 1 |
| Core Tip |
The efficacy of different single agent immune checkpoint inhibitors (ICIs) in metastatic gastric cancer (mGC) treatment varies. ICIs combined with chemotherapy can indeed bring survival benefits to patients with mGC. In the future study, more biomarkers should be explored to clinically evaluate the response of ICI treatment to mGC treatment. |
| Publish Date |
2024-10-30 14:58 |
| Citation |
<p>Li CF, Lian LL, Li QR, Jiao Y. Immunotherapy for metastatic gastric cancer. <i>World J Gastrointest Surg</i> 2024; 16(11): 3408-3412</p> |
| URL |
https://www.wjgnet.com/1948-9366/full/v16/i11/3408.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v16.i11.3408 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
